GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID | UniProt ID | Title | Descriptor ▼ |
---|---|---|---|
7TM0 | P0DTC2 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
7TM0 | 7TM0 | SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement | |
7TN0 | 7TN0 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
7TN0 | Q9BYF1 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
7TN0 | P0DTC2 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
7F9G | 7F9G | Thrombocorticin in complex with Ca2+ and fucose | |
7FAH | C3W5S1 | Immune complex of head region of CA09 HA and neutralizing antibody 12H5 | |
7FAH | 7FAH | Immune complex of head region of CA09 HA and neutralizing antibody 12H5 | |
7MZQ | A0A2X2BLR9 | Crystal structure of the UcaD lectin-binding domain in complex with fucose | |
7MZR | A0A2X2BLR9 | Crystal structure of the UcaD lectin-binding domain in complex with glucose | |
7MZS | A0A2X2BLR9 | Crystal structure of the UcaD lectin-binding domain in complex with galactose | |
7OKV | Q9UNN8 | Crystal structure of soluble EPCR after exposure to the nonionic surfactant Polysorbate 20 | |
7R6J | G0SFD1 | Co-crystal structure of Chaetomium glucosidase with compound 1 | |
7S0K | M1V8A6 | HAP2 from Cyanidioschyzon merolae | |
7S0Q | P08069 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S0Q | P06213 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S0Q | P05019 | Head region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S8V | P08069 | Leg region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7S8V | P06213 | Leg region of a complex of IGF-I with the ectodomain of a hybrid insulin receptor / type 1 insulin-like growth factor receptor | |
7WHU | P08246 | Human Neutrophil Elastase in-complex with Ecotin Peptide | |
7WHU | 7WHU | Human Neutrophil Elastase in-complex with Ecotin Peptide | |
7X1M | 7X1M | The complex structure of Omicron BA.1 RBD with BD604, S309,and S304 | |
7X1M | P0DTC2 | The complex structure of Omicron BA.1 RBD with BD604, S309,and S304 | |
7XAZ | Q9BYF1 | Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 | |
7XAZ | P0DTC2 | Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 | |
7XB0 | Q9BYF1 | Crystal structure of Omicron BA.2 RBD complexed with hACE2 | |
7XB0 | P0DTC2 | Crystal structure of Omicron BA.2 RBD complexed with hACE2 | |
7XB1 | Q9BYF1 | Crystal structure of Omicron BA.3 RBD complexed with hACE2 | |
7XB1 | P0DTC2 | Crystal structure of Omicron BA.3 RBD complexed with hACE2 | |
7Y42 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid | |
8CWU | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21 | |
8CWU | 8CWU | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21 | |
8CWV | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab | |
8CWV | 8CWV | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab | |
8CXN | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 | |
8CXN | 8CXN | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 | |
8CY7 | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 | |
8CY7 | 8CY7 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 | |
8CYA | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 | |
8CYA | 8CYA | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 | |
8CYB | P0DTC2 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 | |
8CYB | 8CYB | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 | |
8D3C | P04275 | VWF tubule derived from monomeric D1-A1 | |
8D3D | P04275 | VWF tubule derived from dimeric D1-A1 | |
8DCC | P0DTC2 | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
8DCC | 8DCC | SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab | |
8DLK | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLK | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7QF7 | Q9UQK1 | Orthorhombic crystal structure of PTG CBM21 in complex with beta-cyclodextrin | |
7QFA | Q9UQK1 | Monoclinic crystal structure of PTG CBM21 in complex with beta-cyclodextrin |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024